Skip to content

Nuvation Bio

US · NUVB #2898 by market cap Listed 1970
3.80 -0.01 -0.26%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 7 in the most recent period (2026/Q3).
  • Total institutional ownership rose 1.8 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
69.07% +1.84pp
Institutions
294 +7
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund44.15%
Individual/Insider17.43%
VC/PE Fund10.09%
Hedge Fund8.96%
Public Company2.86%
Family Office/Trust1.37%
Private Company1.09%
Government Pension Fund0.32%
Insurance Company0.21%
Other13.52%

Top holders as of 2026-03-25

David Hung 17.08% · 60.28M sh
FMR 14.92% · 52.67M sh
BlackRock 8.19% · 28.92M sh
Decheng Capital LLC 7.35% · 25.95M sh
Vanguard Capital Management, LLC 3.44% · 12.15M sh
Omega Fund Management, LLC 2.29% · 8.08M sh
Laurion Capital Management LP 2.18% · 7.70M sh
State Street Global Advisors 2.15% · 7.60M sh
Geode Capital Management, LLC 1.83% · 6.45M sh
Duquesne Family Office LLC 1.29% · 4.54M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 33 buys · 17 sells

NameRoleStake
David Hung Chairperson & CEO 17.08%
William Vernon Independent Director 0.09%
Kathryn Falberg Independent Director 0.07%
Robert Mashal Independent Director 0.06%
Kim Blickenstaff Independent Director 0.05%
Colleen Sjogren Chief Commercial Officer 0.02%
Philippe Sauvage CFO & Principal Financial Officer 0.02%
Kerry Wentworth Chief Regulatory Officer 0.02%
Stacy Markel Chief Human Resources Officer 0.01%
David Hanley Chief Technical Operations Officer 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-08-18 Gary Hattersley Chief Scientific Officer Derivative Exercise and Sale -100,000 $1.87–7.09
2026-07-14 Philippe Sauvage CFO & Principal Financial Officer Derivative Exercise and Retained +40,000 $1.97–2.17
2026-06-22 Kerry Wentworth Chief Regulatory Officer Derivative Exercise and Sale -63,000 $2.93–6.02
2026-06-22 Stacy Markel Chief Human Resources Officer Derivative Exercise and Sale -125,000 $1.74–6.03
2026-06-22 Philippe Sauvage CFO & Principal Financial Officer Derivative Exercise and Sale -47,668 $2.17–6.01
2026-06-22 Moses Makunje VP of Finance and Principal Accounting & Financial Officer Intent to Sell (Form 144) -47,668 $5.76
2026-06-08 Robert Mashal Independent Director Open Market Acquisition +25,000 $4.73
2026-05-20 Kathryn Falberg Independent Director Other Derivative Acquisition +123,397 $4.79
2026-05-20 Kim Blickenstaff Independent Director Other Derivative Acquisition +123,397 $4.79
2026-05-20 Robert Bazemore Lead Independent Director Other Derivative Acquisition +123,397 $4.79
2026-05-20 Robert Mashal Independent Director Other Derivative Acquisition +123,397 $4.79
2026-05-20 William Vernon Independent Director Other Derivative Acquisition +123,397 $4.79
2026-05-20 Xiangmin Cui Independent Director Other Derivative Acquisition +123,397 $4.79
2026-04-16 Kerry Wentworth Chief Regulatory Officer Derivative Exercise and Sale -36,750 $2.93–5.01
2026-04-16 Dongfang Liu -- Derivative Exercise and Sale -50,000 $1.94–5.02
2026-04-05 Kerry Wentworth Chief Regulatory Officer Derivative Exercise and Sale -200,000 $1.87–4.52
2026-02-26 David Hung Chairperson & CEO Other Derivative Acquisition +1,995,012 $5.91
2026-02-26 Kerry Wentworth Chief Regulatory Officer Other Derivative Acquisition +748,130 $5.91
2026-02-26 Xiangmin Cui Independent Director Other Derivative Acquisition +76,923 $5.91
2026-02-26 Stacy Markel Chief Human Resources Officer Other Derivative Acquisition +748,130 $5.91

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Nuvation Bio discussion 0 comments

Add a comment